T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Broadcom
AVGO
|
+$3.01B |
| 2 |
Gilead Sciences
GILD
|
+$1.25B |
| 3 |
Accenture
ACN
|
+$1.09B |
| 4 |
XYZ
Block, Inc.
XYZ
|
+$1.06B |
| 5 |
Valero Energy
VLO
|
+$1.05B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$3.94B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.84B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.47B |
| 4 |
Eli Lilly
LLY
|
+$1.43B |
| 5 |
Tesla
TSLA
|
+$1.4B |
Sector Composition
| 1 | Technology | 30.49% |
| 2 | Healthcare | 13.92% |
| 3 | Financials | 12.27% |
| 4 | Consumer Discretionary | 10.96% |
| 5 | Communication Services | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNR
926
Core Natural Resources, Inc.
CNR
$3.95B
| $22.3M | ﹤0.01% |
289,124
+19,267
| +7% | +$1.49M |
|
927
Tarsus Pharmaceuticals
TARS
$2.09B
| $22.3M | ﹤0.01% |
433,171
-27,602
| -6% | -$1.42M |
|
928
Gulfport Energy Corp
GPOR
$3.02B
| $22.2M | ﹤0.01% |
120,414
-11,062
| -8% | -$2.04M |
|
929
Sapiens International
SPNS
$2.4B
| $22.2M | ﹤0.01% |
817,998
+1,176
| +0.1% | +$31.9K |
|
930
Alcoa
AA
$8.7B
| $22.2M | ﹤0.01% |
726,288
+173,243
| +31% | +$5.28M |
|
931
Masco
MAS
$15.4B
| $21.9M | ﹤0.01% |
315,610
-1,325
| -0.4% | -$92.1K |
|
932
Photronics
PLAB
$1.35B
| $21.5M | ﹤0.01% |
1,035,812
+2,122
| +0.2% | +$44.1K |
|
933
Jacobs Solutions
J
$17.5B
| $21.4M | ﹤0.01% |
179,047
+379
| +0.2% | +$45.4K |
|
934
Qualys
QLYS
$4.77B
| $21.4M | ﹤0.01% |
170,135
+1,426
| +0.8% | +$180K |
|
|
KMTS
935
Kestra Medical Technologies, Ltd. Common Stock
KMTS
$1.16B
| $21.2M | ﹤0.01% |
+849,418
| New | +$21.2M |
|
936
Aptiv
APTV
$18B
| $21.1M | ﹤0.01% |
354,954
-108
| -0% | -$6.43K |
|
937
Hilton Grand Vacations
HGV
$4.01B
| $21.1M | ﹤0.01% |
564,130
+4,716
| +0.8% | +$176K |
|
938
iShares Core S&P 500 ETF
IVV
$679B
| $20.8M | ﹤0.01% |
37,019
-9,520
| -20% | -$5.35M |
|
939
Best Buy
BBY
$15.7B
| $20.7M | ﹤0.01% |
280,800
+2,758
| +1% | +$203K |
|
940
Immunome
IMNM
$825M
| $20.7M | ﹤0.01% |
3,069,607
+786,853
| +34% | +$5.3M |
|
941
CI&T Inc
CINT
$740M
| $20.6M | ﹤0.01% |
3,443,533
-414,460
| -11% | -$2.47M |
|
942
Healthpeak Properties
DOC
$12.7B
| $20.5M | ﹤0.01% |
1,014,594
+20,797
| +2% | +$421K |
|
943
Interparfums
IPAR
$3.41B
| $20.5M | ﹤0.01% |
179,847
+43,709
| +32% | +$4.98M |
|
944
Core & Main
CNM
$9.49B
| $20.5M | ﹤0.01% |
423,646
-20,373
| -5% | -$984K |
|
945
Rocket Pharmaceuticals
RCKT
$347M
| $20.3M | ﹤0.01% |
3,043,682
-104,838
| -3% | -$699K |
|
946
Pentair
PNR
$18.1B
| $20.3M | ﹤0.01% |
231,586
+3,123
| +1% | +$273K |
|
947
Vital Farms
VITL
$2.1B
| $20.2M | ﹤0.01% |
662,058
-116
| -0% | -$3.54K |
|
948
Impinj
PI
$5.55B
| $20.1M | ﹤0.01% |
221,725
+2,644
| +1% | +$240K |
|
949
Molson Coors Class B
TAP
$9.46B
| $20.1M | ﹤0.01% |
329,963
-40,727
| -11% | -$2.48M |
|
950
Invesco Senior Loan ETF
BKLN
$6.89B
| $19.7M | ﹤0.01% |
950,000
| – | – |
|